Search

Search Constraints

You searched for: Author/Creator Bejanin, Alexandre

Search Results

1. 1H‐MRS signature in Alzheimer disease in Down syndrome: Neuroimaging / Optimal neuroimaging measures for tracking disease progression. (7th December 2020)

2. [IC‐P‐059]: DOES APOE‐ε4 HAVE AN Aβ‐INDEPENDENT EFFECT ON TAU PATHOLOGY? NEUROIMAGING INVESTIGATIONS IN COGNITIVELY NORMAL ELDERS AND PATIENTS WITH ALZHEIMER's DISEASE. (1st July 2017)

3. [IC‐P‐176]: TAU PATHOLOGY AND GRAY MATTER ATROPHY CONTRIBUTE TO COGNITIVE IMPAIRMENT IN ALZHEIMER's DISEASE. (1st July 2017)

4. [IC‐P‐186]: AV1451‐PET UPTAKE AND CSF BIOMARKERS IN A HETEROGENEOUS CLINICAL SAMPLE: TWO SIDES OF THE SAME COIN?. (1st July 2017)

5. [O3–03–03]: TAU PATHOLOGY AND GRAY MATTER ATROPHY CONTRIBUTE TO COGNITIVE IMPAIRMENT IN ALZHEIMER's DISEASE. (1st July 2017)

6. [O3–03–04]: AV1451‐PET UPTAKE AND CSF BIOMARKERS IN A HETEROGENEOUS CLINICAL SAMPLE: TWO SIDES OF THE SAME COIN?. (1st July 2017)

7. [P1–031]: DOES APOE‐ε4 HAVE AN Aβ‐INDEPENDENT EFFECT ON TAU PATHOLOGY? NEUROIMAGING INVESTIGATIONS IN COGNITIVELY NORMAL ELDERS AND PATIENTS WITH ALZHEIMER's DISEASE. (1st July 2017)

8. [P1–414]: DOES APOE ε4 HAVE AN Aβ‐INDEPENDENT EFFECT ON TAU PATHOLOGY? NEUROIMAGING INVESTIGATIONS IN COGNITIVELY NORMAL ELDERS AND PATIENTS WITH ALZHEIMER's DISEASE. (1st July 2017)

9. A multimodal study on the effect of sex on Alzheimer's disease clinical and biomarker changes in adults with Down syndrome. (31st December 2021)

10. Alzheimer's disease clinical onset and age at death in people with Down syndrome: A systematic review and population‐based study. (31st December 2021)